Global BGM Device Market 2014-2018

血糖モニタリング機器の世界市場:血糖ストリップ、血糖測定器、ランセット

◆タイトル:Global BGM Device Market 2014-2018
◆商品コード:IRTNTR4487
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年11月5日
◆ページ数:82
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥302,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥378,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"血糖モニタリング機器の世界市場:血糖ストリップ、血糖測定器、ランセット"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、製品別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Blood Glucose Monitoring (BGM)
Diabetes is a disease that occurs when the body is unable to produce insulin, or when the glucose rises above the required levels. Insulin, a hormone produced by the pancreas, is used to process glucose, which acts as a fuel for the tissues. BGM is the process of testing the concentration of insulin or glucose in the blood. A blood glucose meter is a small electronic device used to measure and display the blood glucose level. To measure the level of blood glucose, a small drop of blood is taken by pricking a finger with an instrument called a lancet. The blood is then placed on a disposable blood glucose test strip and this is inserted into a blood glucose meter.

TechNavio’s analysts forecast the Global Blood Glucose Monitoring Device market to grow at a CAGR of 5.26 percent over the period 2013-2018.

[Covered in this Report]
The Global Blood Glucose Monitoring market can be divided into three segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets. This report covers the present scenario and the growth prospects of the Global Blood Glucose Monitoring Device market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of the three segments as mentioned below.
• Blood Glucose Strips
• Blood Glucose Meters
• Lancets
TechNavio’s report, the Global Blood Glucose Monitoring Device Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Blood Glucose Monitoring Device market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• EMEA
• APAC

[Key Vendors]
• Abbott Laboratories
• Arkray
• Bayer Healthcare
• F. Hoffmann-La Roche
• LifeScan

[Other Prominent Vendors]
• B. Braun Melsungen
• Bionime
• DexCom
• GlySens
• Medtronic
• Nipro Diagnostics
• Nova Biomedical
• Terumo Europe

[Market Driver]
• Increase in Diabetic Patients
• For a full, detailed list, view our report

[Market Challenge]
• High Cost of Blood Glucose Monitoring Devices
• For a full, detailed list, view our report

[Market Trend]
• Increased Adoption of Home Healthcare Devices
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Rate of Incidence and Prevalence
Treatment Methods for Diabetic Patients
08. Market Segmentation by Products
08.1 Global Blood Glucose Test Strips Market
08.1.1 Market Size and Forecast
08.2 Global Blood Glucose Meters Market
08.2.1 Market Size and Forecast
08.3 Global Lancets Market
08.3.1 Market Size and Forecast
09. Geographical Segmentation
09.1 BGM Device Market in the Americas
09.1.1 Market Size and Forecast
09.2 BGM Device Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 BGM Device Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Laboratories
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue
18.1.4 Business Segmentation by Revenue 2011 and 2012
18.1.5 Geographical Segmentation by Revenue
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.2 Arkray
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Recent Developments
18.2.5 SWOT Analysis
18.3 Bayer HealthCare
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 F. Hoffmann-La Roche
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation
18.4.4 Business Segmentation by Revenue 2012 and 2013
18.4.5 Geographical Segmentation by Revenue
18.4.6 Business Strategy
18.4.7 Key Information
18.4.8 SWOT Analysis
18.5 LifeScan
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Product Segmentation
18.5.4 Geographical Segmentation by Revenue 2013
18.5.5 Business Strategy
18.5.6 Recent Developments
18.5.7 SWOT Analysis
19. Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global BGM Device Market 2013-2018 (US$ million)
Exhibit 3: Global BGM Distribution Overview 2013
Exhibit 4: Global BGM Devices Market by Treatment Methods 2013
Exhibit 5: Global BGM Device Market Segmentation by Product
Exhibit 6: Blood Glucose Meters Segmentation 2013
Exhibit 7: Global BGM Device Market by Market Segmentation 2013
Exhibit 8: Global Blood Glucose Test Strips Market 2013-2018 (US$ million)
Exhibit 9: Global Blood Glucose Meters Market 2013-2018 (US$ million)
Exhibit 10: Global Lancets Market 2013-2018 (US$ million)
Exhibit 11: Global BGM Device Market by Product Segmentation 2013–2018 (US$ million)
Exhibit 12: Global BGM Device Market by Product Segmentation 2013–2018 (Percentage)
Exhibit 13: Global BGM Device Market by Geographical Segmentation 2013
Exhibit 14: BGM Device Market in the Americas 2013-2018 (US$ million)
Exhibit 15: BGM Device Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 16: BGM Device Market in the APAC Region 2013-2018 (US$ million)
Exhibit 17: Global BGM Device Market by Geographical Segmentation 2013-2018 (US$ million)
Exhibit 18: Global BGM Device Market by Geographical Segmentation 2013-2018 (in percent)
Exhibit 19: Global BGM Device Market by Vendor Segmentation 2013
Exhibit 20: Abbott Laboratories Portfolio Revenue 2013
Exhibit 21: F. Hoffmann-La Roche Diagnostics Sales by Business Area
Exhibit 22: LifeScan Medical Devices and Diagnostics Sales by Major Franchise
Exhibit 23: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 25: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 26: Arkray: Business Segmentation 2013
Exhibit 27: Bayer HealthCare: Business Segmentation by Revenue 2013
Exhibit 28: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 29: Bayer HealthCare: Geographical Segmentation by Revenue 2013
Exhibit 30: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 31: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 32: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 33: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 34: LifeScan: Product Segmentation 2013
Exhibit 35: LifeScan: Geographical Segmentation by Revenue 2013



【掲載企業】

Abbott Laboratories , Arkray , Bayer Healthcare, F. Hoffmann-La Roche , LifeScan , B. Braun Melsungen , Bionime , DexCom , GlySens , Medtronic , Nipro Diagnostics , Nova Biomedical , Terumo Europe

【資料のキーワード】

血糖モニタリング、医療機器、血糖ストリップ、血糖測定器、ランセット、糖尿病

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[血糖モニタリング機器の世界市場:血糖ストリップ、血糖測定器、ランセット] (Global BGM Device Market 2014-2018 / IRTNTR4487)販売に関する免責事項
[血糖モニタリング機器の世界市場:血糖ストリップ、血糖測定器、ランセット] (Global BGM Device Market 2014-2018 / IRTNTR4487)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆